Artrite Psoriásica: Artigos de Revisão II (Psoriatic Arthritis: Reviews II)

■ Psoriatic arthritis: prospects for the future

S Hackett, A Ogdie, L C Coates

Ther Adv Musculoskelet Dis 2022, vol 14: 1759720X221086710

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966104/

■ Harnessing big data, smart and digital Technologies and artificial intelligence for preventing, early intercepting, managing, and treating psoriatic arthritis: insignts from a systematic review of the literature

Nicola Luigi Bragazzi, Charlie Bridgewood, Abdulla Watad, et al

Front Immunol. 2022; 13: 847312

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960164/

■ Metabolic syndrome and its componentes in psoriatic arthritis

Roaa Aljohani

Open Access Rheumatol. 2022; 14: 7–16

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860394/

■ Telemedicine and psoriatic arthritis: best practices and considerations for dermatologists andd rheumatologists

Alice B. Gottlieb, Alvin F. Wells, Joseph F. Merola

Clin Rheumatol. 2022; 41(5): 1271–1283

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791553/

■ Diagnosis and intervantion in early psosiatic arthritis

Tomoyuki Hioki, Mayumi Komine, Mamitaro Ohtsuki

J Clin Med. 2022 Apr; 11(7): 2051

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999837/

■ Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021

Laura C. Coates, Enrique R. Soriano, Nadia Corp et al

the GRAPPA Treatment Recommendations domain subcommittees

Nat Rev Rheumatol. 2022 Jun 27: 1–15

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244095/

■ New insights on juvenile psoriatic arthritis

Francesco Brunello, Francesca Tirelli, Luca Pegoraro et al

Front Pediatr. 2022; 10: 884727

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199423/

■ Psoriatic arthritis: the influence of co-morbidities on drug choice

S Patel, A Kumthekar

Rheumatol Ther 2022, vol 9 (1): 49-71

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814223/

■ New perspectives on diagnosing psoriatic arthritis by imaging techniques

M I Sarbu, N Sarbu, D Cristea et al

Open Acess Rheumatol 2021, vol 13: 343-352

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866993/

■ New insights in physical therapy and rehabilitation in psoriatic arthritis: a review

F M Perrottta, S Scriffignano, D Benfaremo et al

Rheumatol Ther 2021, vol 8 (2): 639-649

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217348/

■ 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis

Jasvinder A. Singh, Gordon Guyatt, Alexis Ogdie et al

Arthritis Care Res (Hoboken). 2019 Jan; 71(1): 2–29

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265826/

■ Predictors, risk factors, and incidence rates of psoriatic arthritis development in psoriasis patients: a systematic literature review and meta-analysis

A Zabotti, O De Lucia, G Sakellariou et al

Rheumatol Ther 2021, vol 8 (4): 1519-1534

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572278/

■ Is there stil a place for methotrexate in severe psoriatic arthritis?

R Felten, G L De Cursay, E Lespessailles

Ther Adv Musculoskelet Dis 2021, vol 13: 1759720×221092376

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021512/

■ Update on the therapeutic management of patients with either psoriatic arthritis or ulcerative colitis: focus on the JAK inhibitor tofacitinib

M S Chimenti, P Conigliaro, L Biancone, R Perricone

Ther Adv Musculoskelet Dis 2021, vol 13: 1759720×20977777

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897839/

■ Biomakers predictive of treatment response in psoriasis and psoriatic arthritis: a systematic review